Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengliang Yang

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
The Lancet. Respiratory Medicine|June 20, 2021
COVID-19 vaccination in patients with α1-antitrypsin deficiencyChengliang Yang, Hedi Zhao
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19Chengliang Yang, Mingyao Liu
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Chengliang Yang, Hedi Zhao
The Lancet Regional Health. Europe|May 3, 2023
Long COVID: the next public health crisis is already on its wayChengliang Yang, Scott J Tebbutt
JAMA|November 4, 2024
Kidney Transplant Outcomes From Donors Who Received DialysisChengliang Yang, Scott J Tebbutt
The New England Journal of Medicine|October 30, 2024
Postacute Sequelae of SARS-CoV-2 Infection in Several ErasChengliang Yang, Scott J Tebbutt
Lancet (London, England)|August 9, 2025
Revisiting the role of α1-antitrypsin deficiency in aortic aneurysms and dissectionsChengliang Yang, Scott J Tebbutt
The New England Journal of Medicine|January 14, 2026
2024-2025 Covid-19 Vaccine Outcomes in U.S. VeteransChengliang Yang, Scott J Tebbutt
BMJ (Clinical Research Ed.)|September 23, 2024
Effects of Medicaid coverage on cardiovascular health outcomesChengliang Yang, Scott J Tebbutt
JAMA|January 27, 2025
Long-Term Prognosis of Patients With MyocarditisChengliang Yang, Scott J Tebbutt
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
The Lancet. Respiratory Medicine|June 20, 2021
COVID-19 vaccination in patients with α1-antitrypsin deficiencyChengliang Yang, Hedi Zhao
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19Chengliang Yang, Mingyao Liu
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Chengliang Yang, Hedi Zhao
The Lancet Regional Health. Europe|May 3, 2023
Long COVID: the next public health crisis is already on its wayChengliang Yang, Scott J Tebbutt
JAMA|November 4, 2024
Kidney Transplant Outcomes From Donors Who Received DialysisChengliang Yang, Scott J Tebbutt
The New England Journal of Medicine|October 30, 2024
Postacute Sequelae of SARS-CoV-2 Infection in Several ErasChengliang Yang, Scott J Tebbutt
Lancet (London, England)|August 9, 2025
Revisiting the role of α1-antitrypsin deficiency in aortic aneurysms and dissectionsChengliang Yang, Scott J Tebbutt
The New England Journal of Medicine|January 14, 2026
2024-2025 Covid-19 Vaccine Outcomes in U.S. VeteransChengliang Yang, Scott J Tebbutt
BMJ (Clinical Research Ed.)|September 23, 2024
Effects of Medicaid coverage on cardiovascular health outcomesChengliang Yang, Scott J Tebbutt
JAMA|January 27, 2025
Long-Term Prognosis of Patients With MyocarditisChengliang Yang, Scott J Tebbutt
Pageof 14